Moat Ross, Chief Corporate and Communications Officer at Kiniksa Pharmaceuticals International ($KNSA), sold about $3.8 million in company shares across seven open market transactions over the past year. His most recent sale occurred on September 4, 2025. These sales rank 2,297th among 11,678 insiders in our database, where the average is $8.6 million across roughly 6.4 transactions per person. Ross made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | A | Share Option | 36950 | $0.00 | 36,950.0000 | 78,979,030 | 9999.99% | 0.05% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | A | Restricted Share Unit | 9250 | $0.00 | 9,250.0000 | 78,979,030 | 9999.99% | 0.01% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | F | Class A Ordinary Share | 1706 | $48.13 | 14,396.0000 | 78,979,030 | 10.59% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | M | Class A Ordinary Share | 5808 | $0.00 | 16,102.0000 | 78,979,030 | 56.42% | 0.01% |
| Jan. 15, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | A | Class A Ordinary Share | 879 | $24.16 | 10,294.0000 | 78,979,030 | 9.34% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | A | Performance Share Unit | 18500 | $0.00 | 18,500.0000 | 78,979,030 | 9999.99% | 0.02% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1611 | $0.00 | 1,161.0000 | 78,979,030 | 58.12% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 1740 | $0.00 | 3,481.0000 | 78,979,030 | 33.33% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF OPERATING OFFICER | M | Restricted Share Unit | 2457 | $0.00 | 7,371.0000 | 78,979,030 | 25.00% | 0.00% |
| Sept. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | S | Class A Ordinary Share | 3523 | $35.31 | 9,415.0000 | 77,942,082 | 27.23% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | M | Class A Ordinary Share | 994 | $0.00 | 13,419.0000 | 77,942,082 | 8.00% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | F | Class A Ordinary Share | 481 | $34.28 | 12,938.0000 | 77,942,082 | 3.58% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | A | Restricted Share Unit | 9828 | $0.00 | 9,828.0000 | 77,942,082 | 9999.99% | 0.01% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | A | Share Option | 39364 | $0.00 | 39,364.0000 | 77,942,082 | 9999.99% | 0.05% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | M | Restricted Share Unit | 1741 | $0.00 | 5,221.0000 | 77,942,082 | 25.01% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | M | Restricted Share Unit | 1611 | $0.00 | 3,222.0000 | 77,942,082 | 33.33% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | M | Restricted Share Unit | 2477 | $0.00 | 2,477.0000 | 77,942,082 | 50.00% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | M | Restricted Share Unit | 994 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | M | Class A Ordinary Share | 1741 | $0.00 | 11,156.0000 | 77,942,082 | 18.49% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | M | Class A Ordinary Share | 1611 | $0.00 | 12,767.0000 | 77,942,082 | 14.44% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | F | Class A Ordinary Share | 2819 | $33.49 | 12,425.0000 | 77,942,082 | 18.49% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF CORP. & COMM. OFFICER | M | Class A Ordinary Share | 2477 | $0.00 | 15,244.0000 | 77,942,082 | 19.40% | 0.00% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 27594 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.04% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 27594 | $13.35 | 37,009.0000 | 76,145,617 | 293.09% | 0.04% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S | Class A Ordinary Share | 27594 | $29.02 | 9,415.0000 | 76,145,617 | 74.56% | 0.04% |
| May 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S | Class A Ordinary Share | 6272 | $28.00 | 9,415.0000 | 76,145,617 | 39.98% | 0.01% |
| May 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 3850 | $17.76 | 13,265.0000 | 76,145,617 | 40.89% | 0.01% |
| May 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S | Class A Ordinary Share | 3850 | $28.00 | 9,415.0000 | 76,145,617 | 29.02% | 0.01% |
| May 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 6272 | $17.76 | 15,687.0000 | 76,145,617 | 66.62% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Performance Share Unit | 4976 | $0.00 | 4,976.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Performance Share Unit | 5225 | $0.00 | 5,225.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Performance Share Option | 8043 | $0.00 | 8,043.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Performance Share Option | 8303 | $0.00 | 8,303.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 3850 | $0.00 | 33,661.0000 | 76,145,617 | 10.26% | 0.01% |
| May 5, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 6272 | $0.00 | 27,389.0000 | 76,145,617 | 18.63% | 0.01% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 15000 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.02% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 7432 | $11.97 | 58,143.0000 | 76,145,617 | 14.66% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 1157 | $0.00 | 37,511.0000 | 76,145,617 | 2.99% | 0.00% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 8671 | $0.00 | 21,059.0000 | 76,145,617 | 29.17% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 13406 | $0.00 | 27,594.0000 | 76,145,617 | 32.70% | 0.02% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 15307 | $0.00 | 23,361.0000 | 76,145,617 | 39.59% | 0.02% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 7432 | $0.00 | 27,252.0000 | 76,145,617 | 21.43% | 0.01% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S | Class A Ordinary Share | 64035 | $25.21 | 9,415.0000 | 76,145,617 | 87.18% | 0.08% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S | Class A Ordinary Share | 23234 | $28.02 | 9,415.0000 | 76,145,617 | 71.16% | 0.03% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 13406 | $13.35 | 22,821.0000 | 76,145,617 | 142.39% | 0.02% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 8671 | $11.10 | 31,492.0000 | 76,145,617 | 38.00% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 1157 | $17.76 | 32,649.0000 | 76,145,617 | 3.67% | 0.00% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 15307 | $10.76 | 73,450.0000 | 76,145,617 | 26.33% | 0.02% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 6296 | $0.00 | 1,658.0000 | 76,145,617 | 79.16% | 0.01% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 20000 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.03% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 15000 | $15.52 | 24,415.0000 | 76,145,617 | 159.32% | 0.02% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 20000 | $15.50 | 44,415.0000 | 76,145,617 | 81.92% | 0.03% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 6296 | $12.97 | 50,711.0000 | 76,145,617 | 14.18% | 0.01% |
| April 21, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S | Class A Ordinary Share | 18259 | $20.29 | 9,415.0000 | 76,145,617 | 65.98% | 0.02% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 2477 | $0.00 | 2,477.0000 | 76,145,617 | 50.00% | 0.00% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 2477 | $0.00 | 28,401.0000 | 76,145,617 | 9.55% | 0.00% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Ordinary Share | 727 | $20.28 | 27,674.0000 | 76,145,617 | 2.56% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 1741 | $0.00 | 26,908.0000 | 76,145,617 | 6.92% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 1611 | $0.00 | 25,167.0000 | 76,145,617 | 6.84% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 1741 | $0.00 | 5,221.0000 | 76,145,617 | 25.01% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 1611 | $0.00 | 3,222.0000 | 76,145,617 | 33.33% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Performance Share Unit | 19657 | $0.00 | 19,657.0000 | 76,145,617 | 9999.99% | 0.03% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Restricted Share Unit | 9828 | $0.00 | 9,828.0000 | 76,145,617 | 9999.99% | 0.01% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Share Option | 39364 | $0.00 | 39,364.0000 | 76,145,617 | 9999.99% | 0.05% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Ordinary Share | 511 | $21.77 | 25,924.0000 | 76,145,617 | 1.93% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Ordinary Share | 473 | $21.77 | 26,435.0000 | 76,145,617 | 1.76% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Ordinary Share | 292 | $22.61 | 23,556.0000 | 71,424,159 | 1.22% | 0.00% |
| Jan. 15, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Class A Ordinary Share | 1118 | $16.00 | 22,854.0000 | 71,424,159 | 5.14% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 994 | $0.00 | 0.0000 | 71,424,159 | 100.00% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 994 | $0.00 | 23,848.0000 | 71,424,159 | 4.35% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Share Option | 36100 | $0.00 | 36,100.0000 | 71,004,640 | 9999.99% | 0.05% |
| July 15, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Class A Ordinary Share | 211 | $15.65 | 18,391.0000 | 71,004,640 | 1.16% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 4089 | $0.00 | 22,480.0000 | 71,004,640 | 22.23% | 0.01% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Ordinary Share | 1393 | $26.74 | 21,087.0000 | 71,004,640 | 6.20% | 0.00% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 994 | $0.00 | 22,081.0000 | 71,004,640 | 4.71% | 0.00% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Ordinary Share | 345 | $26.74 | 21,736.0000 | 71,004,640 | 1.56% | 0.00% |
| Sept. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 14000 | $8.83 | 35,736.0000 | 71,004,640 | 64.41% | 0.02% |
| Sept. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 29730 | $11.10 | 65,466.0000 | 71,004,640 | 83.19% | 0.04% |
| Sept. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Ordinary Share | 24776 | $11.97 | 90,242.0000 | 71,004,640 | 37.85% | 0.03% |
| Sept. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S | Class A Ordinary Share | 67346 | $26.10 | 22,896.0000 | 71,004,640 | 74.63% | 0.09% |
| Sept. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S | Class A Ordinary Share | 1160 | $27.12 | 21,736.0000 | 71,004,640 | 5.07% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Restricted Share Unit | 6962 | $0.00 | 6,962.0000 | 71,004,640 | 9999.99% | 0.01% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 2477 | $0.00 | 4,954.0000 | 71,004,640 | 33.33% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 1612 | $0.00 | 4,833.0000 | 71,004,640 | 25.01% | 0.00% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 994 | $0.00 | 994.0000 | 71,004,640 | 50.00% | 0.00% |
| Sept. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 14000 | $0.00 | 0.0000 | 71,004,640 | 100.00% | 0.02% |
| Sept. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 29730 | $0.00 | 18,534.0000 | 71,004,640 | 61.60% | 0.04% |
| Sept. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Share Option | 24776 | $0.00 | 30,924.0000 | 71,004,640 | 44.48% | 0.03% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Common Share | 2477 | $0.00 | 17,629.0000 | 70,633,023 | 16.35% | 0.00% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Common Share | 1353 | $17.90 | 16,276.0000 | 70,633,023 | 7.67% | 0.00% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Share Option | 36100 | $0.00 | 36,100.0000 | 70,633,023 | 9999.99% | 0.05% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Performance Share Unit | 5569 | $0.00 | 5,569.0000 | 70,633,023 | 9999.99% | 0.01% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Restricted Share Unit | 6962 | $0.00 | 11,795.0000 | 70,633,023 | 144.05% | 0.01% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 2477 | $0.00 | 9,318.0000 | 70,633,023 | 21.00% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Common Share | 1612 | $0.00 | 16,032.0000 | 70,633,023 | 11.18% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Common Share | 880 | $19.70 | 15,152.0000 | 70,633,023 | 5.49% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 1612 | $0.00 | 4,833.0000 | 70,633,023 | 25.01% | 0.00% |
| July 15, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Class A Common Share | 292 | $12.35 | 12,845.0000 | 71,634,729 | 2.33% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Common Share | 2477 | $0.00 | 15,322.0000 | 71,634,729 | 19.28% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Common Share | 1353 | $17.76 | 13,969.0000 | 71,634,729 | 8.83% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Common Share | 994 | $0.00 | 14,963.0000 | 71,634,729 | 7.12% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Common Share | 543 | $17.76 | 14,420.0000 | 71,634,729 | 3.63% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 2477 | $0.00 | 7,431.0000 | 71,634,729 | 25.00% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Restricted Share Unit | 6445 | $0.00 | 6,445.0000 | 71,634,729 | 9999.99% | 0.01% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Share Option | 38668 | $0.00 | 38,668.0000 | 71,634,729 | 9999.99% | 0.05% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 994 | $0.00 | 1,988.0000 | 71,634,729 | 33.33% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 2477 | $0.00 | 7,431.0000 | 69,751,697 | 50.00% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Common Share | 1353 | $10.71 | 12,553.0000 | 69,751,697 | 9.73% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Common Share | 2477 | $0.00 | 13,906.0000 | 69,751,697 | 21.67% | 0.00% |
| April 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Restricted Share Unit | 6445 | $0.00 | 6,445.0000 | 69,751,697 | 9999.99% | 0.01% |
| April 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Share Option | 38668 | $0.00 | 38,668.0000 | 69,751,697 | 9999.99% | 0.06% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Common Share | 994 | $0.00 | 11,002.0000 | 70,421,322 | 9.93% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Common Share | 1167 | $11.12 | 11,429.0000 | 70,421,322 | 9.26% | 0.00% |
| Jan. 15, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | A | Class A Common Share | 1844 | $9.56 | 10,008.0000 | 70,421,322 | 22.59% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 994 | $0.00 | 1,988.0000 | 70,421,322 | 33.33% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Restricted Share Unit | 2137 | $0.00 | 0.0000 | 70,421,322 | 100.00% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | M | Class A Common Share | 2137 | $0.00 | 12,596.0000 | 70,421,322 | 20.43% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | F | Class A Common Share | 543 | $11.46 | 10,459.0000 | 70,421,322 | 4.94% | 0.00% |